๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Placebo-controlled evidence for the use of antidepressants in Generalized Anxiety Disorder

โœ Scribed by E. Salinas

Book ID
118601232
Publisher
Elsevier Science
Year
1999
Tongue
English
Weight
171 KB
Volume
9
Category
Article
ISSN
0924-977X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Escitalopram in the treatment of general
Escitalopram in the treatment of generalized anxiety disorder: Double-blind, placebo controlled, flexible-dose study
โœ Jonathan R.T. Davidson; Anjana Bose; Andrew Korotzer; Hongjie Zheng ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 128 KB ๐Ÿ‘ 2 views

Escitalopram has been shown in clinical trials to improve anxiety symptoms associated with depression, panic disorder, and social anxiety disorder. This study was designed to evaluate the efficacy and tolerability of escitalopram in the treatment of generalized anxiety disorder (GAD). Outpatients (1

Ritanserin in the treatment of generaliz
Ritanserin in the treatment of generalized anxiety disorders: A placebo-controlled trial
โœ E. A. Pangalila-Ratu Langi; A. A. I. Jansen ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 381 KB ๐Ÿ‘ 2 views

In a double-blind trial, 22 patients treated with 5 mg b.i.d. of the selective serotonin-S2 antagonist ritanserin for 4 weeks were compared with 26 patients treated with placebo for generalized anxiety disorder (DSM 111: 300.02). Symptoms were assessed using the Hamilton Anxiety Rating Scale (HARS)